The HPA-1b allele is an inherited risk factor for premature myocardial infarction in men with coronary artery disease, likely due to increased platelet thrombogenicity rather than promoting coronary artery disease itself.
Answers are grounded in this paper and cite their sources.
HPA-1b may mark higher MI risk in CAD patients; hypothesis-generating and requires prospective validation before clinical use.
Conflicting results of an association between the human platelet antigen 1b (HPA-1b or PlA2) allele and the risk of myocardial infarction and coronary artery disease have been reported. To assess the reason for this discrepancy, we determined the HPA-1 genotype in 298 men who had undergone coronary angiography, including 124 individuals with myocardial infarction, 83 individuals with coronary artery disease but no history of myocardial infarction, and 91 control patients. Among patients with acute or recent onset myocardial infarction (< 1 year), the prevalence of HPA-1b was higher than among patients with coronary artery disease but without myocardial infarction (33 percent vs. 14 percent, p = 0.016). In patients under 60 years of age this difference was even more pronounced (45 percent vs. 15 percent, p = 0.003). Unlike conventional risk factors HPA-1b does not represent a risk factor for coronary artery disease itself but appears to be associated with increased platelet thrombogenicity.
No takes yet. Share an insight, caveat, or question.
Zotz et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: